Jupiter Neurosciences, Inc. (JUNS)
NASDAQ: JUNS · Real-Time Price · USD
0.4226
-0.0002 (-0.05%)
At close: Mar 16, 2026, 4:00 PM EDT
0.4142
-0.0084 (-1.99%)
After-hours: Mar 16, 2026, 6:51 PM EDT

Jupiter Neurosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-7.6-2.44-4.78-4.96-4.2-1.65
Stock-Based Compensation
31.841.20.751.30.5
Other Adjustments
0.69-0.750.761.410.38-0.07
Change in Receivables
----0.13-0.13
Changes in Accounts Payable
0.08-0.150.16-0.06-0.160.19
Changes in Accrued Expenses
0.37-02.181.550.850.93
Changes in Other Operating Activities
-0.03-2.4100.06-0.04-0.02
Operating Cash Flow
-3.51-3.91-0.48-1.25-1.74-0.25
Long-Term Debt Issued
00.140.390.980.530.02
Long-Term Debt Repaid
--2.36----0.25
Net Long-Term Debt Issued (Repaid)
0-2.220.390.980.53-0.24
Issuance of Common Stock
0.19.880.06-1.330.7
Net Common Stock Issued (Repurchased)
0.19.880.06-1.330.7
Financing Cash Flow
0.17.650.450.981.860.46
Net Cash Flow
0.723.74-0.04-0.270.120.21
Free Cash Flow
-3.05-3.91-0.48-1.25-1.74-0.25
FCF Margin
----535.19%--22.62%
Free Cash Flow Per Share
-0.09-0.14-0.02---
Levered Free Cash Flow
-5.64-7.23-2.05-2.43-3.6-0.8
Unlevered Free Cash Flow
-5.67-5.66-1.52-1.89-3.22-0.76
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q